The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach

Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies

(2013) C. R. Rayner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics

(2013) Mohamed A. Kamal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combined Effects of Antenatal Receipt of Influenza Vaccine by Mothers and Pneumococcal Conjugate Vaccine Receipt by Infants: Results from a Randomized, Blinded, Controlled Trial

(2013) Saad B. Omer et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Vaccination Given at Least 2 Weeks Before Delivery to Pregnant Women Facilitates Transmission of Seroprotective Influenza-specific Antibodies to the Newborn

(2013) Geraldine Blanchard-Rohner et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oseltamivir Pharmacokinetics and Clinical Experience in Neonates and Infants during an Outbreak of H1N1 Influenza A Virus Infection in a Neonatal Intensive Care Unit

(2012) Joseph F. Standing et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir Dosing in Premature Infants

(2012) C. McPherson et al.   JOURNAL OF INFECTIOUS DISEASES

Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged

(2012) David W. Kimberlin et al.   JOURNAL OF INFECTIOUS DISEASES

Virus Load Kinetics and Resistance Development During Oseltamivir Treatment in Infants and Children Infected With Influenza A(H1N1) 2009 and Influenza B Viruses

(2012) Barbara Rath et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience

(2011) James R. Smith et al.   ADVANCES IN THERAPY

Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants

(2011) Neil Parrott et al.   CLINICAL PHARMACOKINETICS

Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir

(2011) Deshi Shi et al.   JOURNAL OF INFECTIOUS DISEASES

Determination of Appropriate Dosing of Influenza Drugs in Pediatric Patients

(2010) E P Acosta et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Safety and pharmacokinetics of oseltamivir at standard and high dosages

(2010) R. Dutkowski et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Oseltamivir Dosing for Influenza Infection in Premature Neonates

(2010) Edward P. Acosta et al.   JOURNAL OF INFECTIOUS DISEASES

Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin

(2008) Dongfang Yang et al.   BIOCHEMICAL PHARMACOLOGY

Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

(2008) Craig R. Rayner et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

(2008) K. Zaman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology